HomeBusiness & MoneyNovo Nordisk rises as FDA approves Wegovy pill for obesity

Novo Nordisk rises as FDA approves Wegovy pill for obesity


Victor Golmer

  • The US FDA has approved an oral version of Novo Nordisk’s (NVO) blockbuster weight loss therapy, Wegovy (semaglutide).
  • The Wegovy pill is the first GLP-1 oral treatment approved for obesity.
  • Approval was based on results of the OASIS 4 trial, which

Follow us on Google for the latest stock news



Source link

RELATED ARTICLES

Most Popular

Recent Comments